Epe or bni with pathology

Author: rols

August undefined, 2024

WebJun 3, 2024 · SM EPE BNI LVI SVI LNI(5L, 11R): negative, PNI+, nerves spared ... but, being a G9 like me, to make you aware of your adverse pathology, so you stay vigilant and are on top of your PSA. Of the men who do encounter BCR (biochemical recurrence or a concerning rise in PSA to 0.2), two-thirds of them do so in the first 2 years post op, if I ... WebOct 23, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 …

Pathology report - Prostate Cancer Forums

WebMay 1, 2024 · Notably, there were significant differences in progression-free survival between EPE-/mBNI+ or EPE+/mBNI- cases and EPE-/mBNI- (P = .001) or … WebFeb 20, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. LVI and Cribriform pattern present. Decipher .86 High Risk. Post Surgery PSA 3/25/19 .03. (25 days) 4/25/19. < .03. (2 months) … kjdsjspt.uulian.com/player/login

Dr. Epstein / John hopkins biopsy slide second opinion back, …

WebJun 15, 2024 · multifocal EPE, PNI, BNI, bilateral SVI, pT3b N0: Dec 2016: Mrs: Dx stage 4 NHL/DLBCL, Primary Bone Lymphoma spinal RT boost+6X R-CHOP21+6X IT MTX via … WebNov 24, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 … WebJan 30, 2016 · The combination of EPE and negative surgical margins is the most common adverse pathological finding post-surgery, accounting for 60 percent of … recurring high fevers in toddlers

virtual second opinion from Cleveland Clinic - Prostate Cancer …

PSA <0.03 ng/mL... yippie! - HealthBoards

WebJul 3, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. WebMay 18, 2024 · Pathologists look at tissue from the body that is removed during surgery or a biopsy. You will probably never meet the pathologist, but samples of your prostate tissue will be sent to them for review. The pathologist prepares a summary report of their findings, which is called the pathology report. kjdbbjb cast.org.cnWebMar 24, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. LVI and Cribriform pattern present. Decipher .86 High Risk. Post Surgery PSA 3/25/19.03. (25 days) 4/25/19. <.03. (2 months) kjd business solutions llc

"WebJun 5, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 … " - Epe or bni with pathology

Epe or bni with pathology

Ultrasensitive PSA score - Prostate Cancer Forums

WebNov 4, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 … WebFeb 27, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. LVI and Cribriform pattern present. Decipher .86 High Risk. Post Surgery PSA 3/25/19 .03. (25 days) 4/25/19. < .03. (2 months) …

Did you know?

WebJun 5, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. LVI and Cribriform pattern present. Decipher .86 High Risk. Post Surgery PSA 3/25/19 .03. (25 days) 4/25/19. < .03. (2 months) … WebJul 17, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 …

WebOct 26, 2024 · EPE SM SVI LVI BNI all neg., no IDC or cribriform glands 5.2 x 5.1 x 3.7 cm, 45 g, tumor involvement: 6-10% Largest of 3 nodules 2.3 x 1.4 x 1.0 cm, nodule with most Pattern 4: 30% Tags: None Philtoo Senior Member Join Date: Aug 2024 Posts: 163 Share Tweet #2 10-26-2024, 12:46 PM Christopher Wee, MD Cleveland Clinic WebJul 30, 2024 · Given your pathology it is statistically unlikely the surgery resulted in a cure of your prostate cancer and at some time in the future you will need more treatment. The …

WebApr 3, 2024 · multifocal EPE, PNI, BNI, bilateral SVI, pT3b N0: Dec 2016: Mrs: Dx stage 4 NHL/DLBCL, Primary Bone Lymphoma spinal RT boost+6X R-CHOP21+6X IT MTX via LP. Remission ended 2024, Follicular NHL. Currently active surveilance. Mar 2024: older adult son, T-cell acute lymphoblastic leukemia (TALL) Hyper-CVAD + pegaspargase, RBC … WebNov 10, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. LVI and Cribriform pattern present. Decipher .86 High Risk. Post Surgery PSA 3/25/19 .03. (25 days) 4/25/19. < .03. (2 months) …

WebJun 8, 2024 · multifocal EPE, PNI, BNI, bilateral SVI, pT3b N0: Dec 2016: Mrs: Dx stage 4 NHL/DLBCL, Primary Bone Lymphoma spinal RT boost+6X R-CHOP21+6X IT MTX via …

WebMar 29, 2024 · 3/6/19. Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of … recurring hemorrhoid bleedingWebMay 12, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. LVI and Cribriform pattern present. Decipher .86 High Risk. Post Surgery PSA 3/25/19 .03. (25 days) 4/25/19. < .03. (2 months) … recurring hip painWebDec 11, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 Nodes, SV, SM, PNI, and BNI were negative. LVI and Cribriform pattern present. Decipher .86 High Risk. Post Surgery PSA 3/25/19 .03. (25 days) 4/25/19. < .03. (2 months) … recurring hivesWebDec 11, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 … recurring hive in same spotWebAug 2, 2024 · You can also have genomic testing of your cancer's RNA done (on your biopsy slides) to see what the risk is (low, intermediate, or high) of progression to higher … recurring history kjd architectsWebSep 2, 2024 · Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate. 7 … recurring hivin same spot